ANXA5 AND VEGFA GENE VARIANTS
IN WOMEN WITH EARLY PREGNANCY LOSSES
FROM NORTH MACEDONIA
Terzikj M, Bozhinovski Gj, Branoski A, Dimkovska M, Kubelka-Sabit K, Plaseska-Karanfilska D
*Corresponding Author: Corresponding author, Prof. Dijana Plaseska-Karanfilska, MD, PhD.
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov”,
Macedonian Academy of Science and Arts, Skopje, North Macedonia, e-mail: dijana@manu.edu.mk
page: 5
|
|
REFERRENCES
1. Macklon NS, Geraedts JP, Fauser BC. Conception
to ongoing pregnancy: the ‘black box’of early preg-
nancy loss. Human reproduction update. 2002 Jul
1;8(4):333-43
2. Eshre Guideline Group on RPL, Bender Atik R,
Christiansen OB, Elson J, Kolte AM, Lewis S, Mid-
deldorp S, Nelen W, Peramo B, Quenby S, Vermeulen
N. ESHRE guideline: recurrent pregnancy loss. Hu-
man reproduction open. 2018;2018(2):hoy004.
3. Practice Committee of the American Society for Re-
productive Medicine. Definitions of infertility and
recurrent pregnancy loss: a committee opinion. Fertil-
ity and sterility. 2020 Mar 1;113(3):533-5.
4. Regan L, Rai R, Saravelos S, Li TC, Royal College of
Obstetricians and Gynaecologists. Recurrent Miscar-
riage Green‐top Guideline No. 17. BJOG: An Inter-national Journal of Obstetrics &Gynaecology. 2023
Nov;130(12):e9-39.
5. Bozhinovski G, Terzikj M, Kubelka-Sabit K, Jasar
D, Lazarevski S, Livrinova V, Plaseska-Karanfilska
D. Chromosomal Abnormalities in Early Pregnancy
Losses: A Study of 900 Samples. Balkan J Med Genet.
2024 Mar 12;26(2):11-20.
6. Turesheva A, Aimagambetova G, Ukybassova T,
Marat A, Kanabekova P, Kaldygulova L, Aman-
zholkyzy A, Ryzhkova S, Nogay A, Khamidullina
Z, Ilmaliyeva A. Recurrent Pregnancy Loss Etiol-
ogy, Risk Factors, Diagnosis, and Management. Fresh
Look into a Full Box. Journal of Clinical Medicine.
2023 Jun 15;12(12):4074.
7. Bozhinovski G, Terzikj M, Kubelka-Sabit K, Plas-
eska-Karanfilska D. High Incidence of CPLANE1-
Related Joubert Syndrome in the Products of Concep-
tions from Early Pregnancy Losses. Balkan Med J.
2024 Mar 1;41(2):97-104.
8. Deng T, Liao X, Zhu S. Recent advances in treat-
ment of recurrent spontaneous abortion. Obstetrical
& gynecological survey. 2022 Jun;77(6):355.;
9. Gerke V, Moss SE. Annexins: from structure to func-
tion. Physiological reviews. 2002 Apr 1;82(2):331-
71.
10. Cai Z, Zheng X, Chen Y, Chen F, Chen L, Deng X.
Genetic analysis of ANXA5 haplotype and its effect on
recurrent pregnancy loss. Molecular medicine reports.
2022 Feb 1;25(2):1-7.)
11. Bogdanova N, Horst J, Chlystun M, Croucher PJ,
Nebel A, Bohring A, Todorova A, Schreiber S, Gerke
V, Krawczak M, Markoff A. A common haplotype of
the annexin A5 (ANXA5) gene promoter is associated
with recurrent pregnancy loss. Human molecular ge-
netics. 2007 Mar 1;16(5):573-8.10.
12. Ang KC, Bogdanova N, Markoff A, Ch’ng ES, Tang
TH. Association between M2/ANXA5 haplotype and
repeated pregnancy loss: a meta-analysis. Fertility
and sterility. 2019 May 1;111(5):971-81.
13. Peng L, Yang W, Deng X, Bao S. Research progress
on ANXA5 in recurrent pregnancy loss. Journal of
Reproductive Immunology. 2022 Jul 28:103679.
14. Tüttelmann F, Ivanov P, Dietzel C, Sofroniou A, Ts-
vyatkovska TM, Komsa-Penkova RS, Markoff A,
Wieacker P, Bogdanova N. Further insights into the
role of the annexin A5 M2 haplotype as recurrent
pregnancy loss factor, assessing timing of miscar-
riage and partner risk. Fertility and sterility. 2013
Nov 1;100(5):1321-5.
15. Rogenhofer N, Engels L, Bogdanova N, Tüttelmann
F, Markoff A, Thaler C. Paternal and maternal car-
riage of the annexin A5 M2 haplotype are equal risk
factors for recurrent pregnancy loss: a pilot study.
Fertility and sterility. 2012 Aug 1;98(2):383-8.
16. Miyamura H, Nishizawa H, Ota S, Suzuki M, Inagaki
A, Egusa H, Nishiyama S, Kato T, Pryor-Koishi K,
Nakanishi I, Fujita T. Polymorphisms in the annexin
A5 gene promoter in Japanese women with recurrent
pregnancy loss. Molecular human reproduction. 2011
Jul 1;17(7):447-52.
17. Demetriou C, Abu-Amero S, White S, Peskett E,
Markoff A, Stanier P, Moore GE, Regan L. Investiga-
tion of the Annexin A5 M2 haplotype in 500 white
European couples who have experienced recurrent
spontaneous abortion. Reproductive biomedicine
online. 2015 Nov 1;31(5):681-8.
18. Tiscia G, Colaizzo D, Chinni E, Pisanelli D, Scian-
namè N, Favuzzi G, Margaglione M, Grandone E.
Haplotype M2 in the annexin A5 (ANXA5) gene and
the occurrence of obstetric complications. Thrombo-
sis and haemostasis. 2009;102(08):309-13.
19. Lan Y, Wang J, Zhang Q, Yang X, Li L, Yin J, Li
H, Song X, Chen Z, Liu Y. Genetic variations and
haplotypes in the annexin A5 gene are associated
with the risk of recurrent pregnancy loss. Journal of
cellular physiology. 2019 Oct;234(10):18308-16.
20. Ang KC, Kathirgamanathan S, Ch’ng ES, Lee YY,
Roslani AL, Naidu B, Kumar K, Abdullah R, Kadir
SN, Yusoff NM, Abdullah WZ. Genetic analysis of
the M2/ANXA5 haplotype as recurrent pregnancy loss
predisposition in the Malay population. Journal of as-
sisted reproduction and genetics. 2017 Apr;34:517-24.
21. Dryllis G, Giannopoulos A, Zoi C, Pouliakis A, Logo-
thetis E, Voulgarelis M, Zoi K, Kouskouni E, Dinou
A, Stavropoulos-Giokas C, Kreatsas G. Correlation of
single nucleotide polymorphisms in the promoter re-
gion of the ANXA5 (annexin A5) gene with recurrent
miscarriages in women of Greek origin. The Journal
of Maternal-Fetal & Neonatal Medicine. 2020 May
2;33(9):1538-43.
22. Cao Y, Zhang Z, Xu J, Yuan W, Wang J, Huang X,
Shen Y, Du J. The association of idiopathic recurrent
pregnancy loss with polymorphisms in hemostasis-
related genes. Gene. 2013 Nov 10;530(2):248-52.
23. Nagirnaja L, Nõmmemees D, Rull K, Christiansen
OB, Nielsen HS, Laan M. Annexin A5 promoter
haplotype M2 is not a risk factor for recurrent preg-
nancy loss in Northern Europe. PLoS One. 2015 Jul
2;10(7):e0131606.
24. Sinem AY, Fatma S, Servet OH, Ahmet U, Emine C,
Ozturk O. Fetal Vegf genotype is more important for
abortion risk than mother genotype. CanakkaleOn-
Sekiz Mart University, Turkey (2014).
25. Papazoglou D, Galazios G, Papatheodorou K, Liberis
V, Papanas N, Maltezos E, et al. Vascular endothelial
growth factor gene polymorphisms and idiopathic re-
current pregnancy loss. FertilSteril (2005);83:959–6.
26. Sun Y, Chen M, Mao B, Cheng X, Zhang X, Xu C.
Association between vascular endothelial growth
factor polymorphism and recurrent pregnancy loss:
A systematic review and meta-analysis. European
Journal of Obstetrics & Gynecology and Reproduc-
tive Biology. 2017 Apr 1;211:169-76.
27. Xu X, Du C, Li H, Du J, Yan X, Peng L, Li G, Chen
ZJ. Association of VEGF genetic polymorphisms
with recurrent spontaneous abortion risk: a system-
atic review and meta-analysis. PLoS One. 2015 Apr
20;10(4):e0123696.
28. Trifonova EA, Swarovskaya MG, Ganzha OA, Vo-
ronkova OV, Gabidulina TV, Stepanov VA. The inter-
action effect of angiogenesis and endothelial dysfunc-
tion-related gene variants increases the susceptibil-
ity of recurrent pregnancy loss. Journal of Assisted
Reproduction and Genetics. 2019 Apr 15;36:717-26.
29. Su MT, Lin SH, Chen YC. Genetic association studies
of angiogenesis-and vasoconstriction-related genes in
women with recurrent pregnancy loss: a systematic
review and meta-analysis. Human Reproduction Up-
date. 2011 Nov 1;17(6):803-12.
30. Eller AG, Branch DW, Nelson L, Porter TF, Silver
RM. Vascular endothelial growth factor-A gene
polymorphisms in women with recurrent pregnancy
loss. Journal of reproductive immunology. 2011 Jan
1;88(1):48-52.
31. Fortis MF, Fraga LR, Boquett JA, Kowalski TW, Du-
tra CG, Gonçalves RO, Vianna FS, Schüler-Faccini L,
Sanseverino MT. Angiogenesis and oxidative stress-
related gene variants in recurrent pregnancy loss.
Reproduction, Fertility and Development. 2018 Mar
13;30(3):498-506.
32. Noveski P, Terzic M, Vujovic M, Kuzmanovska M,
Sukarova Stefanovska E, Plaseska-Karanfilska D.
Multilevel regression modeling for aneuploidy clas-
sification and physical separation of maternal cell
contamination facilitates the QF-PCR based analysis
of common fetal aneuploidies. Plos one. 2019 Aug
20;14(8):e0221227.
33. Madjunkova S, Volk M, Peterlin B, Plaseska-Karan-
filska D. Detection of thrombophilic mutations related to spontaneous abortions by a multiplex SNaPshot
method. Genetic testing and molecular biomarkers.
2012 Apr 1;16(4):259-64.
34. Atanasovska B, Bozhinovski G, Plaseska-Karanfilska
D, Chakalova L. Efficient detection of Mediterra-
nean β-thalassemia mutations by multiplex single-
nucleotide primer extension. PLoS One. 2012 Oct
26;7(10):e48167.
35. Plaseski T, Noveski P, Popeska Z, Efremov GD,
Plaseska‐Karanfilska D. Association study of sin-
gle‐nucleotide polymorphisms in FASLG, JMJDIA,
LOC203413, TEX15, BRDT, OR2W3, INSR, and
TAS2R38 genes with male infertility. Journal of an-
drology. 2012 Jul 8;33(4):675-83.
36. Rogenhofer N, Markoff A, Wagner A, Klein HG,
Petroff D, Schleussner E, EThIG II Group, Thaler
CJ. Lessons from the EThIGII trial: proper puta-
tive benefit assessment of low-molecular-weight
heparin treatment in M2/ANXA5 haplotype carriers.
Clinical and Applied Thrombosis/Hemostasis. 2017
Jan;23(1):27-33. 37. Fishel S, Baker DJ, Greer IA. LMWH in IVF–Bio-
markers and benefits. Thrombosis Research. 2017
Mar 1;151:S65-9.
38. Vuorela P, Carpen O, Tulppala M, Halmesmäki E.
VEGF, its receptors and the tie receptors in recurrent
miscarriage. Molecular human reproduction. 2000
Mar 1;6(3):276-82.
39. Plaisier M, Dennert I, Rost E, Koolwijk P, Van Hins-
bergh VW, Helmerhorst FM. Decidual vasculariza-
tion and the expression of angiogenic growth factors
and proteases in first trimester spontaneous abortions.
Human reproduction. 2009 Jan 1;24(1):185-97.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
